Novo Nordisk boasts a strong expertise in diabetes and other critical areas of medicine. Medtronic offers a rich and growing portfolio of products as well as a solid dividend.
Good financial results from two peers lifted sentiment on the medical-device maker. Medtronic has also been doing well lately, and those companies' performances indicate more growth could be coming.
Is Medtronic a good buy right now?

Medtronic (MDT) Stock Moves -0.23%: What You Should Know

09:50pm, Wednesday, 12'th Apr 2023 Zacks Investment Research
In the latest trading session, Medtronic (MDT) closed at $80.81, marking a -0.23% move from the previous day.

3 Stocks That Already Doubled in 2023 and Could Keep Climbing

09:39am, Tuesday, 11'th Apr 2023 The Motley Fool
The gains these stocks notched in the first few months of the year could be the beginning of a much longer bull run.
The Procter & Gamble, PepsiCo, Bank of America, Medtronic and Blackstone are part of the Zacks Top Analyst Blog.
As the population of our country continues to age, treatments and disease detection will continue to increase in demand. Additionally, improvements in imaging, robotics, and AI technology continue to
These two pharma stocks have kept their businesses stable and have steadily paid dividends.

2 Top Healthcare Stocks to Buy Right Now

12:40pm, Friday, 07'th Apr 2023 The Motley Fool
The demand for healthcare is positioned to steadily rise in the future.
Johnson & Johnson is undergoing significant changes, but its solid foundation makes it an excellent buy. Medtronic's long-term prospects are bright, thanks to the burgeoning medical device industry.

Dividend Growth Investing Like Peter Lynch

09:00am, Friday, 07'th Apr 2023
Although Peter Lynch wasn't explicitly a dividend growth investor, his principles and advice are highly applicable to a dividend growth strategy. Certain categories and sectors of stocks work better f

2 Top Healthcare Stocks to Buy Right Now

08:40am, Friday, 07'th Apr 2023
Medtronic and Cigna are dominant businesses in the medical devices and health insurance industries, respectively. Both companies should have promising dividend growth prospects.
"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing. 67 Aristocrats, screened as of April 5, 2023, repr
My passive income stream grew by 22.63% in February and by 46.87% in March. Read more as I review my February and March results in this piece.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE